Vyne Therapeutics Inc (VYNE) — Cash Flow Quality Index

Latest as of March 2022: -1.94x

Vyne Therapeutics Inc (VYNE) has a Cash Flow Quality Index of -1.94x as of March 2022. Operating cash flow of $-9.04 Million is below net income of $4.67 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Vyne Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.94x

Operating CF / Net Income

Operating Cash Flow

$-9.04 Million

USD

Net Income

$4.67 Million

USD

Data as of

Mar 2022

Most recent filing

Annual Cash Flow Quality Index for Vyne Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Vyne Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.